The global urine analyzers market size is expected to be valued at US$ 4.6 Billion in 2022 and US$ 8.3 Billion in 2032. It is set to exhibit growth at a robust CAGR of 6.2% in the forecast period from 2022 to 2032. The rising prevalence of liver and kidney diseases, diabetes, and Urinary Tract Infection (UTI) is likely to augment the demand for urine analyzers in the evaluation period.
| Report Attribute | Details |
| Urine Analyzers Market Estimated Base Year Value (2021) | US$ 3.1 Billion |
| Urine Analyzers Market Expected Market Value (2022) | US$ 4.6 Billion |
| Urine Analyzers Market Anticipated Forecast Value (2032) | US$ 8.3 Billion |
| Urine Analyzers Market Projected Growth Rate (2022-2032) | 6.2% CAGR |
Urine analyzers are innovative devices that are used in clinics and hospitals to perform automatic testing. These help to identify microscopic, chemical, and physical properties of an individual’s urine.
The increasing usage of these analyzers for various applications, such as diagnosis of diabetes, pregnancy, kidney disorder, and urinary tract infection is set to drive the market in future years. The growing awareness regarding the availability of various types of analyzers is another significant factor that is estimated to propel the market.
These are highly accurate and easy to handle and these properties are set to make them immensely popular in hospitals. As per the National Kidney Foundation, in the U.S., 1 in 3 adults is at high risk of developing kidney diseases, while an estimated 37 million people are affected by the disease in the country. The rising prevalence of liver and kidney diseases across the globe is set to bode well for the market.
The rising healthcare expenditure and the increasing proportion of health-conscious people across the globe are projected to bode well for the urine analyzers market growth. The rapid inclination of patients towards advanced analyzers from manual testing equipment is another vital factor that is likely to drive the market in the near future.
The ever-increasing geriatric population living with several age-associated diseases in both developed and developing countries is set to boost the market. As per the World Health Organization (WHO), the proportion of the global population over 60 years is expected to double to 22% from 12% between 2015 and 2050. This trend is likely to continue throughout the forthcoming years, thereby propelling the market.
The easy availability of refurbished products is a crucial factor that may hamper the sales of urine analyzers in the assessment period. These products provide the same functionalities as that of brand new instruments at a relatively lower cost.
In emerging economies, medium- and small-scale laboratories are expected to prefer cost-effective and refurbished products. There may also be an influx of refurbished and low-quality products in these economies owing to the absence of well-grounded regulatory frameworks.
The presence of a well-established healthcare infrastructure in Canada and the U.S. is estimated to push the North America urine analyzers market share during the forecast period. In addition to that, the rising launch of technologically advanced instruments, increasing aging population, and implementation of favorable government norms are anticipated to augur well for the market.
Several renowned companies based in this region are set to engage in collaborations and agreements to expand their portfolios. In August 2020, for instance, Sysmex America, Inc. signed an agreement with Siemens Healthineers to distribute and service the latter’s CLINITEK Novus Automated Urine Analyzer across North America. The increasing number of similar other developments in the market is likely to aid the regional growth.
The surging number of research and development activities in Japan, China, and India associated with urine testing is projected to spur the Asia Pacific urine analyzers market growth in future. In March 2022, for instance, Researchers at Nagoya University, Japan, came up with a liquid biopsy test for the screening of brain cancer. The MicroRNA urine test is capable of identifying brain cancer in patients with tumors accurately. Thus, the development of such tests is set to accelerate the market.
Besides, the increasing disposable income, high disease prevalence, easy availability of health insurance coverage, and expansion of the medical tourism industry in India are anticipated to bolster the market. According to the India Brand Equity Foundation (IBEF), the gross direct premium income recorded by health insurance companies in FY1 grew 13.3% YoY to US$ 7.9 billion in the country. These numbers are likely to surge at a fast pace in the near future, which is anticipated to positively affect the market.
Some of the leading players operating in the urine analyzers market are DIALAB GmbH, 77 Elektronika Kft., Siemens Healthineers, Inc., Beckman Coulter Inc., Roche Holding AG, Mindray Medical International Limited, and Dae Kyoung Ind. Co., Ltd. among others.
Some of the renowned companies are increasingly focusing on the rapid development of cutting-edge products to cater to the high unmet needs. A few other key players are engaging in mergers and acquisitions with regional companies to co-develop new products. Meanwhile, a handful of firms are striving to expand their manufacturing capacities and set up new production facilities to broaden their geographic presence.
| Report Attribute | Details |
| Growth Rate | CAGR of 6.2% from 2022 to 2032 |
| Base Year for Estimation | 2021 |
| Historical Data | 2015-2020 |
| Forecast Period | 2022-2032 |
| Quantitative Units | Revenue in USD Billion, Volume in Kilotons and CAGR from 2022-2032 |
| Report Coverage | Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis |
| Segments Covered |
|
| Regions Covered |
|
| Key Countries Profiled |
|
| Key Companies Profiled |
|
| Customization | Available Upon Request |
By Product Type:
By End Use:
By Test Type:
By Region:
The global urine analyzers market is likely to exceed US$ 8.3 Billion by 2032.
North America is expected to dominate the urine analyzers market.
DIALAB GmbH, 77 Elektronika Kft., Siemens Healthineers, Inc., Beckman Coulter Inc., Roche Holding AG, Mindray Medical International Limited, and Dae Kyoung Ind. Co., Ltd. are some of the prominent urine analyzers manufacturers.
Explore Similar Insights
Urine Analyzers Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
